Cue Health Inc.

HLTHQ · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue$64,223$483,476$618,107$22,953
% Growth-86.7%-21.8%2,592.9%
Cost of Goods Sold$127,091$329,973$276,542$14,951
Gross Profit-$62,868$153,503$341,565$8,002
% Margin-97.9%31.7%55.3%34.9%
R&D Expenses$150,620$171,452$42,829$28,478
G&A Expenses$57,355$97,103$79,788$23,936
SG&A Expenses$89,939$185,683$108,517$24,650
Sales & Mktg Exp.$32,584$88,580$28,729$714
Other Operating Expenses$91,426$0$0$0
Operating Expenses$331,985$357,135$151,346$53,128
Operating Income-$394,853-$203,632$190,219-$45,126
% Margin-614.8%-42.1%30.8%-196.6%
Other Income/Exp. Net$26,182-$172-$71,042-$2,226
Pre-Tax Income-$368,671-$203,804$119,177-$47,352
Tax Expense$4,793-$9,748$32,759$0
Net Income-$373,464-$194,056$33,108-$47,352
% Margin-581.5%-40.1%5.4%-206.3%
EPS-2.44-1.310.23-0.33
% Growth-86.3%-669.6%169.7%
EPS Diluted-2.44-1.310.23-0.33
Weighted Avg Shares Out152,877148,025146,403145,624
Weighted Avg Shares Out Dil152,877148,025146,403145,624
Supplemental Information
Interest Income$6,240$3,328$108$0
Interest Expense$1,159$645$9,809$374
Depreciation & Amortization$56,278$54,880$37,818$6,868
EBITDA-$311,234-$148,279$166,804-$39,500
% Margin-484.6%-30.7%27%-172.1%